✦ LIBER ✦

Frequent occurance of lamivudine resistant mutants in HBeAg (+) but not in HBeAg (−) patients with chronic hepatitis B

✍ Scribed by H. Bozkaya; C. Yurdaydin; A.M. Bozdayi; N. Aslan; H. Verdi; K. Çinar; H. Çetinkaya; Ö. Uzunalimoglu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extended lamivudine treatment in patient

✍ Mario Rizzetto; Nicholas C. Tassopoulos; Robert D. Goldin; Rafael Esteban; Teres 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 175 KB

HBeAG loss among chronic hepatitis B HBe

✍ H.W.L. Hann; D.M. Rosenberg; M.L. Funk; S. Hawley; R. Davis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Predictors for early HBeAg loss during l

✍ Cheng-Yuan Peng; Chih-Bin Chen; Hsueh-Chou Lai; Wen-Pang Su; Po-Heng Chuang; Hon 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 188 KB

Telbivudine in combination with adefovir

✍ Sang-Hoon Ahn, Young-Oh Kweon, Seung-Woon Paik, Joo-Hyun Sohn, Kwan-Sik Lee, Don 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 272 KB

Comparison of lamivudine monotherapy wit

✍ Z. Karasu; G. Ersoz; U. Akarca; F. Gunsar; R. Vardar; Y. Batur 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 267 KB

504 Twenty-four months combination thera

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB